• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of personalized therapy with molecularly targeted anticancer drugs based on next-generation sequencing and PK/PD models

Research Project

Project/Area Number 21K06708
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 47060:Clinical pharmacy-related
Research InstitutionAkita University (2023)
Tohoku University (2021-2022)

Principal Investigator

Masafumi Kikuchi  秋田大学, 医学部附属病院, 教授 (90420025)

Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2023: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2022: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywordsがんクリニカルシーケンス / 分子標的抗がん薬 / PK/PD / Modeling & Simulation / 個別化医療
Outline of Research at the Start

近年、がんクリニカルシーケンス検査に基づき「最適な薬剤」の選択が実践されているが、遺伝子変異に適合した薬剤はほとんどが適応外となるばかりか、小児などのスペシャルポピュレーションが対象となることも多い。そのため、Pharmacokinetics(PK)/Pharmacodynamics(PD)の関連性は明らかになっておらず、「最適な用法・用量」は定まっていない。
そこで今回、分子標的抗がん薬の「有効血中濃度域」をがん種や遺伝子変異毎に精査し、Modeling & Simulationにより患者背景に基づく「最適な用法・用量」を解明することで、さらなる個別化薬物療法を確立する。

Outline of Final Research Achievements

To establishment of personalized therapy with molecularly targeted anticancer drugs based on next-generation sequencing and pharmacokinetic/pharmacodynamic (PK/PD) models, we developed a quantification method for oral molecularly targeted anticancer drugs using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS). Using this quantification method, we determined the association between blood lenvatinib concentration and adverse events in hepatocellular carcinoma, the prediction accuracy of blood lenvatinib concentration using nonlinear mixed effects model (NONMEM), and the association between blood imatinib concentration and antitumor effect in glioma patients with activating mutations of platelet derived growth factor receptor alpha (PDGFRA).

Academic Significance and Societal Importance of the Research Achievements

LC-MS/MSを用いた20種の経口分子標的抗がん薬とその代謝物のハイスループットな一斉定量法は、汎用性が高く、臨床だけでなく、多くの研究に活用することが可能である。また、NONMEMを用いて、様々ながん種における血中レンバチニブ濃度を予測できる可能性を明らかにしたことは、がんクリニカルシーケンスと分子標的抗がん薬のPK/PDモデルに基づく個別化医療の確立に大きく貢献することが期待される。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (23 results)

All 2023 2022 2021

All Journal Article (8 results) (of which Peer Reviewed: 8 results,  Open Access: 3 results) Presentation (13 results) (of which Invited: 5 results) Book (2 results)

  • [Journal Article] Development of a Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analytical Method for Urinary Endogenous Substrates and Metabolites for Predicting Cytochrome P450 3A4 Activity2023

    • Author(s)
      Masaki Kumondai, Masamitsu Maekawa, Eiji Hishinuma, Yu Sato, Toshihiro Sato, Masafumi Kikuchi, Masahiro Hiratsuka, Nariyasu Mano
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 46 Issue: 3 Pages: 455-463

    • DOI

      10.1248/bpb.b22-00840

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2023-03-01
    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors2023

    • Author(s)
      Kumondai Masaki、Kikuchi Masafumi、Mizuguchi Atsushi、Hayashi Nagomi、Ui Masahiro、Hirama Takashi、Okada Yoshinori、Sato Yu、Sato Toshihiro、Maekawa Masamitsu、Mano Nariyasu
    • Journal Title

      The Tohoku Journal of Experimental Medicine

      Volume: 260 Issue: 1 Pages: 29-34

    • DOI

      10.1620/tjem.2023.J016

    • ISSN
      0040-8727, 1349-3329
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] High throughput LC/ESI-MS/MS method for simultaneous analysis of 20 oral molecular-targeted anticancer drugs and the active metabolite of sunitinib in human plasma2023

    • Author(s)
      Hirasawa T, Kikuchi M, Takasaki S, Kumondai K, Sato Y, Sato, Imoto E, Hayakawa Y, Maekawa M, Mano N
    • Journal Title

      Heliyon

      Volume: 9 Issue: 6 Pages: e16926-e16926

    • DOI

      10.1016/j.heliyon.2023.e16926

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database2023

    • Author(s)
      Tsuchiya M, Obara T, Kikuchi M, Mano N
    • Journal Title

      Cancer Chemotherapy and Pharmacology

      Volume: 91 Issue: 6 Pages: 501-506

    • DOI

      10.1007/s00280-023-04535-6

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Shifting the linear range of the calibration curves for the quantification of oral molecular-targeted anticancer drugs and the active metabolite in human plasma using LC-ESI-MS/MS2022

    • Author(s)
      Tensei Hirasawa, Masafumi Kikuchi, Shinya Takasaki, Masaki Kumondai, Yu Sato, Toshihiro Sato, Eishi Imoto, Yoshihiro Hayakawa, Masamitsu Maekawa, Nariyasu Mano
    • Journal Title

      Medical Mass Spectrometry

      Volume: 6 Issue: 1 Pages: 52-63

    • DOI

      10.24508/mms.2022.06.006

    • ISSN
      2432-7441, 2432-745X
    • Year and Date
      2022-06-25
    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Evaluation of a capillary microsampling device for analyzing plasma lenvatinib concentration in patients with hepatocellular carcinoma2022

    • Author(s)
      Akihiro Saito, Masafumi Kikuchi, Yuko Matsumoto, Erina Sugawara, Gesshu Takao, Hayato Inomata, Akane Takahashi, Yuji Sato, Masaki Kumondai, Yu Sato, Toshihiro Sato, Masashi Ninomiya, Jun Inoue, Masamitsu Maekawa, Nariyasu Mano
    • Journal Title

      Therapeutic Drug Monitoring

      Volume: 44 Issue: 6 Pages: 771-776

    • DOI

      10.1097/ftd.0000000000001013

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] High‐throughput liquid chromatography/electrospray ionization?tandem mass spectrometry method using in‐source collision‐induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma2021

    • Author(s)
      Hirasawa Tensei、Kikuchi Masafumi、Shigeta Kensuke、Takasaki Shinya、Sato Yu、Sato Toshihiro、Ogura Jiro、Onodera Koichi、Fukuhara Noriko、Onishi Yasushi、Maekawa Masamitsu、Mano Nariyasu
    • Journal Title

      Biomedical Chromatography

      Volume: 35 Issue: 8

    • DOI

      10.1002/bmc.5124

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma2021

    • Author(s)
      Takasaki Shinya、Kawasaki Yoshihide、Ito Akihiro、Yamaguchi Hiroaki、Mano Nariyasu
    • Journal Title

      Journal of Pharmacy & Pharmaceutical Sciences

      Volume: 24 Pages: 127-136

    • DOI

      10.18433/jpps31816

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Presentation] シクロスポリンおよびダナゾールとの併用により、血中ベネトクラクス濃度が高値を示した急性骨髄性白血病の1例2023

    • Author(s)
      植木悠悟、菊地正史、公文代將希、大槻彩夏、石川大雅、福田朱理、小林大典、佐藤祐司、前川 正充、眞野 成康
    • Organizer
      日本病院薬剤師会東北ブロック第12回学術大会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 肺移植患者における複数のCYP3A阻害薬とシロリムスおよびタクロリムスの相互作用を考慮した投与量設計2023

    • Author(s)
      公文代將希、菊地正史、水口敦史、林和未、宇井雅博、平間崇、岡田克典、佐藤裕、佐藤紀宏、前川正充、眞野成康
    • Organizer
      日本病院薬剤師会東北ブロック第12回学術大会
    • Related Report
      2023 Annual Research Report
  • [Presentation] マイクロサンプリングデバイスを用いたヒト血漿中レンバチニブ濃度定量法の開発2023

    • Author(s)
      菊地正史、齊藤明博、佐藤祐司、公文代將希、佐藤裕、佐藤紀宏、二宮匡史、井上淳、前川正充、眞野成康
    • Organizer
      医療薬学フォーラム2023
    • Related Report
      2023 Annual Research Report
  • [Presentation] Microsampling WingTMを用いたヒト血漿中レンバチニブ濃度定量法の開発2023

    • Author(s)
      菊地正史、眞野成康
    • Organizer
      第55回日本臨床検査医学会東北支部総会・第34回日本臨床化学会東北支部総会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] LC-MS/MSを用いる向精神薬一斉分析法の構築に向けた基礎的検討2023

    • Author(s)
      前川正充、佐藤紀宏、佐藤裕、公文代將希、菊地正史、眞野成康
    • Organizer
      第55回日本臨床検査医学会東北支部総会・第34回日本臨床化学会東北支部総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 血中薬物濃度測定におけるLC-MS/MSの活用と精度管理2023

    • Author(s)
      菊地正史、佐藤祐司、前川正充、眞野成康
    • Organizer
      第63回日本臨床化学会年次学術集会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] LC-MS/MSを用いた血中薬物濃度のハイスループット定量法の開発と臨床実装2023

    • Author(s)
      菊地正史、眞野成康
    • Organizer
      第33回日本医療薬学会年会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] がんゲノム医療におけるがん遺伝子パネル検査の基礎知識2023

    • Author(s)
      菊地正史、眞野成康
    • Organizer
      日本臨床腫瘍薬学会学術大会2023
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] レンバチニブによる破壊性甲状腺炎を発現した肝細胞癌の2例2022

    • Author(s)
      菅原英里奈、菊地正史、鷹尾月舟、松本侑子、齊藤明博、公文代將希、佐藤裕、二宮匡史、井上淳、眞野成康
    • Organizer
      日本医療薬学会 第5回フレッシャーズ・カンファランス
    • Related Report
      2022 Research-status Report
  • [Presentation] 進行腎癌に対するニボルマブ+イピリムマブ併用療法の初回投与後に劇症1型糖尿病を発症した一例2022

    • Author(s)
      朝倉聡美、今野壮太、高橋麻由子、堀川美帆、菊地正史、眞野成康
    • Organizer
      日本病院薬剤師会東北ブロック第11回学術大会
    • Related Report
      2022 Research-status Report
  • [Presentation] LC/ESI-MS/MSを用いた経口分子標的抗がん薬及び代謝物の一斉定量法の開発2022

    • Author(s)
      菊地正史、平澤天晴、髙﨑新也、公文代將希、佐藤裕、佐藤紀宏、前川正充、眞野成康
    • Organizer
      第32回日本医療薬学会年会
    • Related Report
      2022 Research-status Report
  • [Presentation] LC-MS/MSを用いた血中薬物濃度測定における精度管理2021

    • Author(s)
      菊地正史、髙﨑新也、前川正充、眞野成康
    • Organizer
      第37回日本TDM学会学術大会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] LC/ESI-MS/MSを用いた経口分子標的抗がん薬及び代謝物の一斉定量条件の検討2021

    • Author(s)
      平澤天晴、菊地正史、髙﨑新也、公文代將希、佐藤裕、佐藤紀宏、前川正充、眞野成康
    • Organizer
      第46回日本医用マススペクトル学会年会
    • Related Report
      2021 Research-status Report
  • [Book] 今日の臨床検査2023-20242023

    • Author(s)
      矢冨裕、山田俊幸、下澤達雄、佐藤健夫、松井啓隆、長尾美紀、眞野成康、菊地正史
    • Total Pages
      620
    • Publisher
      南江堂
    • ISBN
      9784524233199
    • Related Report
      2023 Annual Research Report
  • [Book] 今日の臨床検査2021-20222021

    • Author(s)
      櫻林郁之介、矢冨 裕、廣畑俊成、山田俊幸、石黒厚至、眞野成康、菊地正史
    • Total Pages
      768
    • Publisher
      南江堂
    • ISBN
      9784524228034
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi